BridgeBio logo

BridgeBio

ID: 6456393

BridgeBio is a San Francisco-based biotechnology researching and producing genetically-targeted therapeutics.

8

Funding Rounds

$1.6b

Money raised

Overview

BridgeBio is a San Francisco-based biotechnology researching and producing genetically-targeted therapeutics.

Unlock Complete Company Intelligence

Access comprehensive data and insights available only to Seedtable members

Financial Details

  • • Complete funding history and valuations
  • • Revenue estimates and financial metrics
  • • Investment round details and terms

People & Contacts

  • • Complete leadership team profiles
  • • Contact information and email addresses
  • • Board members and advisors

Market Intelligence

  • • Competitive landscape analysis
  • • Market position and growth metrics
  • • Industry benchmarking data

Premium Tools

  • • Export data and generate reports
  • • Save companies to custom watchlists
  • • API access for data integration

Join 10,000+ Professionals

Trusted by investors, founders, and analysts worldwide

Access detailed insights on 71,000+ companies worldwide

Funding

Funding series

Funding Series Analysis

The company BridgeBio has raised a total of $1.38b in funding over 8 rounds.

Key Insights:

  • BridgeBio Venture round, March 2020: $475m
  • BridgeBio Pharma , January 2019: $299m
  • BridgeBio Series D round, January 2019: $299.2m
  • BridgeBio Pharma , September 2017: $135m
  • BridgeBio Series C round, September 2017: $135m
  • BridgeBio Series B round, May 2017: $33.1m
  • BridgeBio Series B round, March 2016: $6.9m
  • BridgeBio Venture round, January 2021: $250m

Subsidiaries

BridgeBio operates through the following subsidiaries: